Retatrutide – Overview & Benefits
We aim to simplify peptide research by offering:
Retatrutide is a triple incretin agonist that activates GLP-1, GIP, and glucagon receptors simultaneously,
designed for maximum weight loss and metabolic improvement. By combining appetite reduction, improved
insulin action, and fat mobilization, it sets a new standard in obesity management.
📚
Retatrutide 6-Month Dosing Guide (1:1 Reconstitution)
Victory Peptides – We keep peptide reconstitution simple.
With a 1:1 ratio (10 mg powder + 1 mL water = 10 mg/mL),
the math is easy: 1 mg = 10 units on a U-100 insulin syringe.
Overview & Benefits
Produces greater weight loss than current GLP-1 or dual agonist drugs
Improves insulin sensitivity, glycemic control, and energy balance
Stacks well with Cagrilintide, AOD-9604, and Tesamorelin for advanced fat-loss and body
composition results
Improves insulin sensitivity, glycemic control, and energy balance
Stacks well with Cagrilintide, AOD-9604, and Tesamorelin for advanced fat-loss and body
composition results
Snap 8
Reduces the depth of wrinkles caused by facial expressions
Supports smoother skin and improved texture
Stacks well with GHK-Cu, Argireline, and Hyaluronic Acid in skincare protocols
Supports smoother skin and improved texture
Stacks well with GHK-Cu, Argireline, and Hyaluronic Acid in skincare protocols
💉 Dosing Protocol
This protocol involves a single daily injection with gradual titration:
- Daily Dose: Begin with 400 mcg (10 units) and increase to 1,200 mcg (30 units) as tolerated
- Injection Frequency: Once daily, preferably at the same time each day
- Cycle Length: 12 weeks (adjustable based on research parameters)
- Note: Ensure consistent dosing intervals and accurate measurement using a 100-unit insulin syringe